Anti-Inflammatory Agents
Biomarkers
C-Reactive Protein
Double-Blind Method
Drug Therapy, Combination
Eicosapentaenoic Acid
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Inflammation Mediators
Lipids
Metabolic Syndrome
Time Factors
Treatment Outcome